Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Douglas M Willis
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 14 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 14 Dec, 2021
Edits made to:
Infobox
(
-11
properties)
Infobox
Patent primary examiner of
US Patent 11166973 Substituted nucleotides and nucleosides for treating viral infections
US Patent 11173157 Substituted pyrimidines containing acidic groups as TLR7 modulators
US Patent 11174250 Substituted carboxamides as inhibitors of WDR5 protein-protein binding
US Patent 11179354 Substituted cycloalkanes for managing nephrogenic diabetes insipidus
US Patent 11180494 Substituted amino acids as integrin inhibitors
US Patent 11180498 Substituted pyrrolo[2,3-b]pyridines, pyrazolo[3,4-d]pyrimidines and [1,2,3]triazolo[4,5-b]pyridines as potent antivirals
US Patent 11180504 Substituted carbapenems for the treatment of bacterial infections
US Patent 11185545 Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid
US Patent 11186578 Substituted pyrrolo[3,2-d]pyrimidines and pyrazolo[4,3-d]pyrimidines as tyrosine kinase inhibitors
US Patent 11186581 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(6-(2-hydroxyphenyl)pyridazin-3-yl)acetamide as a Wnt pathway modulator
US Patent 7642264 Phenyl-substituted pyrimidine derivatives as mGluR antagonists
Edits on 3 Dec, 2021
Golden AI
edited on 3 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7642264 Phenyl-substituted pyrimidine derivatives as mGluR antagonists
Edits on 2 Dec, 2021
Golden AI
edited on 2 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 11186581 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(6-(2-hydroxyphenyl)pyridazin-3-yl)acetamide as a Wnt pathway modulator
Golden AI
edited on 2 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 11186578 Substituted pyrrolo[3,2-d]pyrimidines and pyrazolo[4,3-d]pyrimidines as tyrosine kinase inhibitors
Golden AI
edited on 2 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 11185545 Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid
Edits on 25 Nov, 2021
Golden AI
edited on 25 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 11180504 Substituted carbapenems for the treatment of bacterial infections
Golden AI
edited on 25 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 11180498 Substituted pyrrolo[2,3-b]pyridines, pyrazolo[3,4-d]pyrimidines and [1,2,3]triazolo[4,5-b]pyridines as potent antivirals
Golden AI
edited on 25 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 11180494 Substituted amino acids as integrin inhibitors
Golden AI
edited on 25 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 11179354 Substituted cycloalkanes for managing nephrogenic diabetes insipidus
Edits on 18 Nov, 2021
Golden AI
edited on 18 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 11174250 Substituted carboxamides as inhibitors of WDR5 protein-protein binding
Edits on 18 Nov, 2021
Golden AI
edited on 18 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 11173157 Substituted pyrimidines containing acidic groups as TLR7 modulators
Edits on 11 Nov, 2021
Golden AI
edited on 11 Nov, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 11166973 Substituted nucleotides and nucleosides for treating viral infections
"Created via: Entity Importer"
Golden AI
created this topic on 11 Nov, 2021
Edits made to:
Infobox
(
+2
properties)
Douglas M Willis
Infobox
Is a
Person
Current Employer
United States Patent and Trademark Office
Find more people like Douglas M Willis
Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE